DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a prominent player in the biotechnology sector, is set to take part in the Maxim Healthcare Virtual Summit this week. The company’s President and CEO, Dr. Oren Gilad, will be featured in two key sessions during the event, which caters to leaders in biotechnology, diagnostics, medical devices, and healthcare information technology.
Dr. Gilad will first join the “Precision and Immune Oncology Panel” scheduled for Wednesday, October 16, from 2:00 to 3:00 PM ET. This session promises to delve into the latest advancements and strategies in precision medicine and immune oncology, highlighting cutting-edge developments and their potential impact on patient care.
The following day, Dr. Gilad will participate in a “Fireside Chat” on Thursday, October 17, from 3:30 to 4:00 PM ET. This discussion will provide attendees with insights into Aprea Therapeutics’ innovative approaches and future directions, offering a comprehensive overview of the company’s strategic initiatives in the healthcare landscape.
Hosted live on M-Vest, the Maxim Healthcare Virtual Summit brings together senior analysts and key management from a wide range of leading healthcare companies. The event serves as a vital platform for exchanging ideas and fostering collaboration across the industry.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.